Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03462836Withdrawn
Randomised trial of ketamine and Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (2 arms), sponsored by Yonsei University. Primary endpoint: natural killer cell cytotoxicity. Planned start Apr 2019; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03462836.